Pulmonary Arterial Hypertension

Showing 1 - 25 of 429

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • +3 more
  • 129Xe Hyperpolarized
  • Durham, North Carolina
    Duke University Medical Center
Oct 23, 2023

Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

Active, not recruiting
  • Pulmonary Vascular Disease
  • +2 more
  • Relocation from HA to LA
  • Zurich, Switzerland
    Respiratory Clinic, University Hospital of Zurich
Oct 17, 2023

Pulmonary Arterial Hypertension, Dilated Cardiomyopathy, Congenital Heart Disease Trial (IntelliStent)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • +2 more
  • IntelliStent
  • (no location specified)
Oct 6, 2023

Pulmonary Arterial Hypertension, Right Heart Failure, Right Ventricular Dysfunction Trial in Seattle (Valsartan 40 mg, Placebo)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • +3 more
  • Valsartan 40 mg
  • Placebo
  • Seattle, Washington
    University of Washington Medical Center
Sep 13, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Oral zamicastat)

Completed
  • Pulmonary Arterial Hypertension
  • Oral zamicastat
  • Linz, Austria
  • +10 more
Aug 18, 2023

Submaximal CPET in Treatment Management of PAH

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Shape II CPET
  • Torrance, California
  • +5 more
Aug 4, 2023

Pulmonary Arterial Hypertension Trial in Sydney (Dose A KER-012, Dose B KER-012, Dose C KER-012)

Recruiting
  • Pulmonary Arterial Hypertension
  • Dose A KER-012
  • +3 more
  • Sydney, Australia
    Macquarie University
Jul 27, 2023

Pulmonary Arterial Hypertension, Healthy Trial in Rochester (Aerobic Training, Leg Training)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Healthy
  • Aerobic Training
  • Leg Training
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 20, 2023

Pulmonary Arterial Hypertension Trial in Shanghai (TPN171H)

Completed
  • Pulmonary Arterial Hypertension
  • Shanghai, China
    Fu Zhu
Jul 6, 2023

Pulmonary Arterial Hypertension Trial in Peshawar (Supervised endurance exercise training + Patient Education, Home exercises +

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Supervised endurance exercise training + Patient Education
  • Home exercises + Patient Education
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
  • +1 more
Jul 7, 2023

Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • L608 Inhalation Solution
  • Placebo solution
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Jul 12, 2023

Pulmonary Arterial Hypertension Trial in Kansas City (Placebo, Seralutinib, Generic Dry Powder Inhaler)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Placebo
  • +2 more
  • Kansas City, Kansas
    University of Kansas Medical Center
Jun 28, 2023

d Plasma Volume in Pulmonary Hypertension

Completed
  • Pulmonary Arterial Hypertension
  • +2 more
    • (no location specified)
    May 5, 2023

    Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension Trial in Beijing (Rituximab)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Pulmonary Arterial Hypertension
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 13, 2023

    Pulmonary Arterial Hypertension Trial (Selexipag, Riociguat, CardioMEMS pulmonary artery pressure monitor)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • (no location specified)
    Apr 11, 2023

    Pulmonary Arterial Hypertension Trial (Sotatercept)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • Sotatercept
    • (no location specified)
    Apr 5, 2023

    Pulmonary Arterial Hypertension Trial (LTP001)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • (no location specified)
    Mar 16, 2023

    StratosPHere (Non-interventional Study)

    Completed
    • Pulmonary Arterial Hypertension
    • +3 more
      • Cambridge, England, United Kingdom
        University of Cambridge Heart and Lung Research Institute
      Mar 2, 2023

      Lung in Pulmonary Artery Hypertension (PAH)

      Not yet recruiting
      • Pulmonary Arterial Hypertension
      • Healthy
      • TSPO PET scan (11C-PBR28)
      • (no location specified)
      Feb 16, 2023

      Pulmonary Arterial Hypertension Participants Treated With

      Recruiting
      • Pulmonary Arterial Hypertension
      • PAH medication
      • Acquaviva Delle Fonti, Italy
      • +34 more
      Feb 1, 2023

      Pulmonary Arterial Hypertension Trial in Cincinnati (Sotatercept)

      Recruiting
      • Pulmonary Arterial Hypertension
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center ( Site 1602)
      Jan 31, 2023

      Pulmonary Arterial Hypertension Trial in Montreal (Lidocaine, Placebo)

      Terminated
      • Pulmonary Arterial Hypertension
      • Montreal, Quebec, Canada
        Jewish General Hospital
      Jan 30, 2023

      PAH, Pulmonary Hypertension, Hypertension Trial in Worldwide (Ralinepag, Placebo)

      Recruiting
      • PAH
      • +10 more
      • Tucson, Arizona
      • +36 more
      Jan 27, 2023

      PAH Trial in Worldwide (sotatercept)

      Recruiting
      • Pulmonary Arterial Hypertension
      • PAH
      • Sotatercept
      • Phoenix, Arizona
      • +167 more
      Jan 27, 2023